ProCE Banner Activity

Integrating New Data From CROI 2023

Slideset

Download slides to review expert insights on the most clinically relevant data presented at CROI 2023, as well as other key studies that may be significant to the advancement of HIV patient care. 

Released: March 17, 2023

Expiration: March 15, 2024

Share

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Viiv Healthcare

ViiV Healthcare

Faculty Disclosure

Princy N. Kumar, MD, FIDSA, MACP: consultant/advisor/speaker: Gilead Sciences, Johnson & Johnson, Merck, Theratechnologies, ViiV; researcher: American Gene Technologies, Gilead Sciences, GlaxoSmithKline, Merck; stock/stock options: Gilead, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS, has no relevant financial relationships to disclose.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCPconsultant/advisor/speaker: Gilead Sciences, Janssen, Merck, ViiV Healthcare.

Joseph J. Eron, Jr., MD: consultant/advisor/speaker: Gilead Sciences, GSK, Janssen, Merck, ViiV Healthcare; researcher: Gilead Sciences, ViiV Healthcare.